SCHEMBL5483588

SCHEMBL5483588

COc1nc(N)c(-c2ccccc2)c(OC)c1C#N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 5/20 0.54
ADORA2A P29274 8/20 0.50
KDM4E B2RXH2 4/20 0.50
HSD17B10 Q99714 3/20 0.50
RXFP1 Q9HBX9 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
ADRA2A P08913 1/20 0.50
HTT P42858 1/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ADORA1 P30542 7/20 0.49
GSK3A P49840 1/20 0.46
GSK3B P49841 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28383673 0.85 KDM4E (0.66) SQORADORA2AKDM4EHSD17B10RXFP1
SCHEMBL5483590 0.79 SQOR (0.56) SQORADORA2AKDM4EHSD17B10RXFP1
SCHEMBL26632999 0.77 ADORA2A (0.60) SQORADORA2AKDM4EHSD17B10RXFP1
SCHEMBL7830291 0.74 POLB (0.59) SQORADORA2AKDM4EALDH1A1MAPT
SCHEMBL7022233 0.74 SQOR (0.57) SQORADORA2AKDM4EHSD17B10RXFP1
SCHEMBL7021847 0.74 SQOR (0.56) SQORADORA2AKDM4EHSD17B10RXFP1
SCHEMBL6461004 0.74 KDM4E (0.70) SQORADORA2AKDM4EHSD17B10RXFP1
SCHEMBL5483601 0.74 ADORA1 (0.58) ADORA2AKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL7020664 0.74 SQOR (0.56) SQORADORA2AKDM4EHSD17B10RXFP1
SCHEMBL6440715 0.74 ADORA1 (0.72) SQORADORA2AADORA1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors WYETH 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors CNKSR1, MAP3K1, MAP3K6 SQOR 3992/4885ADORA2A 1009/4885KDM4E 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.